Solution Study
Monday, September 25
04:00 PM - 04:30 PM
Live in Berlin
Less Details
Pharma and Cell and Gene manufacturers are constantly innovating to meet new demands in areas such as personalized medicine and treatments for diseases. Advanced manufacturing technologies are critical in order to keep up with evolving trends and mitigate drug shortages.
While companies are making improvements in their digital maturity, there is still an abundance of paper on the manufacturing floor. The problem with paper? Process inefficiency, missing or unusable data, preventable human errors, delayed review and release, and excessive rework and scrap.
In this presentation, we will illustrate how technology is directly delivering a return on investment in these areas. Using data from Manufacturing Excellence customers, we will share real-world metrics and how companies are thriving when using an electronic batch record (EBR).
Additionally, we will discuss implementation tactics and lessons learned from our customers. Often companies are hesitant to make the shift to digital thinking that implementation will create major disruption in current process and adoption levels will be low. Today’s modern MES technology has addressed these issues and we can explain how low-code, no-code software is configurable to your process, easier to implement and provides a seamless user interface for our customers. Join this session to learn more about real-world experiences with modern MES technology.
This presentation covers:
Michelle Janas has more than thirteen years’ experience in biologics, API, medical device and pharmaceuticals. Prior to joining MasterControl as a Regional Account Executive, she held a variety of roles across quality and manufacturing including serving as Grünenthal Group’s Global GxP & eCompliance Director. From releasing production records to implementing software at manufacturing sites all over the globe, her expertise spans functions from global quality assurance to operational excellence.